Hospital Santa Creu i Sant Pau

Barcelona, Barcelona 08025

0 studies enrolling now · 2 studies all time

What they study most

Metastatic Bladder Cancer, Reduction of Hypertrophic Skin Scarring, Urinary Tract Neoplasms, Urologic Neoplasms

Studies at this site

• A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer — Completed
• Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery — Completed